Cardiovascular comorbidities of pediatric psoriasis among hospitalized children in the United States

[1]  J. Silverberg,et al.  Association Between Inflammatory Skin Disease and Cardiovascular and Cerebrovascular Co-Morbidities in US Adults: Analysis of Nationwide Inpatient Sample Data , 2017, American Journal of Clinical Dermatology.

[2]  J. Roliński,et al.  Psoriasis and metabolic syndrome in children: current data , 2017, Clinical and experimental dermatology.

[3]  T. Torres,et al.  Cardiovascular comorbidities in childhood psoriasis , 2014, European Journal of Dermatology.

[4]  G. Jemec,et al.  Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. , 2013, Journal of the American Academy of Dermatology.

[5]  M. Lahfa,et al.  Childhood‐onset psoriasis: association with future cardiovascular and metabolic comorbidities , 2013, The British journal of dermatology.

[6]  L. Herrinton,et al.  Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996–2009 , 2013, Pharmacoepidemiology and drug safety.

[7]  Rosa Parisi,et al.  Global epidemiology of psoriasis: a systematic review of incidence and prevalence. , 2013, The Journal of investigative dermatology.

[8]  S. Fichtlscherer,et al.  Effective continuous systemic therapy of severe plaque‐type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  C. Koebnick,et al.  The association of psoriasis and elevated blood lipids in overweight and obese children. , 2011, The Journal of pediatrics.

[10]  Chun-Ying Wu,et al.  Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis. , 2009, Journal of the American Academy of Dermatology.

[11]  Cynthia S Crowson,et al.  Potential misclassification of patients with psoriasis in electronic databases. , 2008, Journal of the American Academy of Dermatology.

[12]  I. Rebelo,et al.  Clinical and Laboratory Investigations The inflammatory response in mild and in severe psoriasis , 2004 .

[13]  G. Chodorowska,et al.  C‐reactive protein and α2‐macroglobulin plasma activity in medium–severe and severe psoriasis , 2004, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  L. Skov,et al.  Cardiovascular risk factors in children and adolescents with psoriasis: a case-control study. , 2014, Acta dermato-venereologica.

[15]  Susun Bellew,et al.  Epidemiology and comorbidity of psoriasis in children , 2011 .

[16]  I. Rebelo,et al.  Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. , 2001, Clinica chimica acta; international journal of clinical chemistry.